Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NR1D inhibitors(Nuclear receptor subfamily 1 group D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H30F2N2 |
InChIKeyWQVFAUSKMZPMRE-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | IT | 20 Dec 2023 |